Skip to main content
Clinical Trials/NCT02355548
NCT02355548
Completed
Not Applicable

Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism

Intermountain Health Care, Inc.1 site in 1 country200 target enrollmentDecember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Embolism
Sponsor
Intermountain Health Care, Inc.
Enrollment
200
Locations
1
Primary Endpoint
90-day all-cause mortality, recurrent VTE, and Major Bleeding during outpatient treatment of Low-risk PE
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study is looking at the safety and effectiveness of treating Patients diagnosed with a low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient hospitalization. Patients have several medical tests done during their Emergency Department visit. Based on those tests, those who are determined to have a low-risk PE are eligible to participate in the study. Those choosing to participate are discharged after 12 hours of medical observation. Patients who choose to participate are followed up by telephone approximately 90 days later.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
December 2017
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pulmonary Embolism, diagnosed by CTA or high probability VQ Scan
  • Total Pulmonary Embolism Severity Index (PESI) score \<86

Exclusion Criteria

  • Massive Pulmonary Embolism: Hypotension with signs of right heart strain on CTA or Echocardiogram
  • Sustained Systolic Blood Pressure (SBP) \<95 mmHg during Emergency Department or observation stay.
  • Renal insufficiency (Creatinine Clearance \<30)
  • Hepatic Dysfunction (AST/ALT/ALP \> 3 times upper limit of normal)
  • Unreliable social situation or inability to follow up
  • Contraindication to enoxaparin, warfarin and rivaroxaban
  • Atrial or ventricular dysrhythmia(s)

Outcomes

Primary Outcomes

90-day all-cause mortality, recurrent VTE, and Major Bleeding during outpatient treatment of Low-risk PE

Time Frame: 90 Days

This is a composite outcome of the above.

Secondary Outcomes

  • Level of patient satisfaction as measured by survey.(90 Days Post study enrollment)
  • Reduction of medical costs due to outpatient treatment.(90 Days)

Study Sites (1)

Loading locations...

Similar Trials